Factors contributing to anaemia after uncomplicated Plasmodiumfalciparum malaria in children.
The factors contributing to anaemia in falciparum malaria were characterized in 1261 prospectively studied children in an endemic area of southwestern Nigeria. Of these, 487 (39%) presented with anaemia (haematocrit <30%). The following were found to be independent risk factors for anaemia at presentation: age <5 years, history of illness >3 days before presentation, presence of fever, a palpable liver, >parasitaemia 10,000/microl blood, and gametocytaemia. The mean maximum fractional fall in haematocrit (FFH) after treatment was 13.8% (95% confidence interval [CI] 13-14.6) of the baseline value. This occurred 3 days after treatment began and correlated positively with enrolment haematocrit. In children whose haematocrit was >30% at enrolment, the following were found to be independent risk factors associated with subsequent development of anaemia during follow-up: age <5 years and parasitaemia > or =100,000 parasites/microl. Haematological recovery was usually complete by 4-5 weeks, but was slower in children who were anaemic at enrolment and in those with recrudescence of their infections. Half of the children with recrudescence were still anaemic at 4 weeks. These findings have implications for the control of the burden of malarial anaemia in children in sub-Saharan African countries.
Sowunmi
Akintunde
A
Department of Pharmacology & Therapeutics, Institute for Medical Research and Training, University of Ibadan, Ibadan, Nigeria. akinsowunmi@hotmail.com
Gbotosho
Grace O
GO
Happi
Christian T
CT
Fateye
Babasola A
BA
D000740:Anemia / Q000453:epidemiology / Q000209:etiology*; D000962:Antimalarials / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005260:Female; D005334:Fever / Q000150:complications; D006400:Hematocrit; D006801:Humans; D016778:Malaria, Falciparum / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000469:parasitology; D008297:Male; D009549:Nigeria / Q000453:epidemiology; D018512:Parasitemia / Q000150:complications / Q000188:drug therapy / Q000276:immunology / Q000469:parasitology; D010963:Plasmodium falciparum / Q000472:pathogenicity*; D015995:Prevalence; D012307:Risk Factors; D016896:Treatment Outcome
D000962:Antimalarials